A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.

Christopher PleyerXin TianShakuntala RampertaapRui MuSusan SotoJeanine SuperataErika M GaglioneClare SunJennifer LotterMaryalice Stetler-StevensonConstance M YuanIrina MaricStefania PittalugaSergio RosenzweigThomas FleisherAdrian WiestnerInhye E Ahn

Published in: American journal of hematology (2020)

Keyphrases

chronic lymphocytic leukemia
phase ii study
open label
locally advanced
placebo controlled
squamous cell carcinoma
rectal cancer
radiation therapy
study protocol
double blind